GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Aquestive Therapeutics
Aquestive Therapeutics develops medications in the form of thin films that dissolve in the mouth. Its stock price reflects both the potential of this unique delivery technology and the binary risks associated with obtaining FDA approval for its key products.
Share prices of companies in the market segment - Pharma other
Aquestive Therapeutics develops and commercializes drugs using its thin film delivery technology (Filmstrip). We classify it within the "Pharmaceuticals (Other)" segment because it focuses on innovative drug delivery methods. The chart below shows the overall performance of this technology-driven pharmaceutical subsector.
Broad Market Index - GURU.Markets
Aquestive Therapeutics is a pharmaceutical company specializing in the development of thin-film formulations that dissolve in the mouth. Its unique technology makes it part of the GURU.Markets index. The chart below compares its performance with the overall market.
Change in the price of a company, segment, and market as a whole per day
AQST - Daily change in the company's share price Aquestive Therapeutics
Shares of Aquestive, a pharmaceutical company, exhibit high volatility. change_co measures the company's sensitivity to regulatory decisions and clinical trial data for its unique drug delivery technology. This metric is important for analyzing risks in innovative pharmaceuticals on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma other
Aquestive Therapeutics, Inc. is a pharmaceutical company. This chart highlights the sector's high volatility. Comparison with AQST, with its unique film-based drug delivery technology, helps assess its risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
Aquestive is a pharmaceutical company specializing in innovative oral drug delivery systems. The pharmaceutical sector is known for its high volatility. The chart below shows average daily fluctuations in the industry, allowing one to assess how Aquestive's performance compares to overall trends.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Aquestive Therapeutics
Aquestive is a biopharmaceutical company. Its shares, like many in the sector, are volatile and react to news about clinical trials. These science-driven movements are part of the overall stock market landscape.
Annual dynamics of market capitalization of the market segment - Pharma other
Aquestive Therapeutics, Inc. is a pharmaceutical company with a unique thin-film drug delivery technology. This chart shows how the market perceives the commercial success of its approved products and the potential of its platform for new drug development.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aquestive Therapeutics is a biopharmaceutical company whose stock performance is driven by the commercialization of its products and progress in research. The company's business is not dependent on economic cycles. This chart reflects biotech events, not macroeconomic data.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Aquestive Therapeutics
Aquestive, a pharmaceutical company, is valued based on its product cycle. Monthly fluctuations on the chart reflect news related to FDA approval and the commercial launch of its flagship product, a sublingual film containing epinephrine, the success of which determines its future.
Monthly dynamics of market capitalization of the market segment - Pharma other
This chart reflects the dynamics of the biotech sector. For Aquestive, with its unique film-based drug delivery technology, it's the backdrop. Its volatile movements demonstrate how investor expectations surrounding FDA approval of its drugs are impacting the entire industry.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aquestive Therapeutics develops and commercializes thin-film medications that dissolve in the mouth, offering an alternative to tablets and injections. The full-market chart allows you to assess how Aquestive's shares are performing as they transition from development to commercial growth, and how its unique technology allows it to withstand overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Aquestive Therapeutics
Aquestive Therapeutics, which develops oral film-based medications, is extremely sensitive to news. Its weekly stock price reflects FDA decisions, clinical trial data, and partnerships.
Weekly dynamics of market capitalization of the market segment - Pharma other
Aquestive, like other companies in its sector, is susceptible to the overall mood in biotech. Regulatory news from the FDA, general drug pricing trends, and investor risk appetite all impact everyone. The chart below allows you to compare whether AQST stands out from the crowd thanks to its unique drug delivery technology.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Aquestive Therapeutics, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on FDA decisions. The chart below clearly demonstrates how AQST shares can rise or fall on its own news while the overall market remains stagnant.
Market capitalization of the company, segment and market as a whole
AQST - Market capitalization of the company Aquestive Therapeutics
Aquestive Therapeutics' market capitalization is a story of innovation in drug delivery methods. The company specializes in developing film-based medications that dissolve in the mouth. Its market capitalization chart reflects its successes and setbacks in obtaining approvals for its products, demonstrating how the market values this niche but promising technology.
AQST - Share of the company's market capitalization Aquestive Therapeutics within the market segment - Pharma other
Aquestive Therapeutics develops drugs delivered via oral film, an alternative to tablets and injections. Its share of its pharmaceutical segment's market capitalization reflects the potential of this unique technology. The chart below shows how investors value its developments, particularly the Libervant anti-seizure spray.
Market capitalization of the market segment - Pharma other
Aquestive Therapeutics develops thin-film medications for oral administration, offering an alternative to tablets and injections. The chart below shows the pharmaceutical sector's market capitalization. This represents a market where innovations in drug delivery methods could radically change treatment.
Market capitalization of all companies included in a broad market index - GURU.Markets
Aquestive Therapeutics is developing a unique drug delivery technology in the form of thin films that dissolve in the mouth. The company's market capitalization is a bet that its delivery method can improve existing drugs. On the scale of the pharmaceutical industry as a whole, its value is derived from the weight of innovations aimed not at creating new molecules, but at improving the way they are administered.
Book value capitalization of the company, segment and market as a whole
AQST - Book value capitalization of the company Aquestive Therapeutics
Aquestive Therapeutics is based on a proprietary drug delivery technology. The company's book value reflects its intellectual property in the PharmFilm® technology (soluble films) and the manufacturing capacity needed to produce them. The chart below shows how the company utilizes its capital to apply its unique platform to various drugs.
AQST - Share of the company's book capitalization Aquestive Therapeutics within the market segment - Pharma other
Aquestive Therapeutics develops and manufactures film-formulated drugs in-house. This unique production line is its key material asset. The S_BCap_Seg graph shows its share of the innovative pharmaceutical infrastructure.
Market segment balance sheet capitalization - Pharma other
Against the backdrop of the capital-intensive pharmaceutical industry with its gigantic factories, Aquestive has chosen the path of a technological innovator. Its value lies in its film-based drug delivery platform. This makes its model relatively "lightweight," focusing on R&D rather than large-scale production.
Book value of all companies included in the broad market index - GURU.Markets
Aquestive Therapeutics develops innovative drug delivery systems through thin films that dissolve in the mouth. The company's assets include patented technology and production lines for these "smart" films. The graph shows the material weight of this alternative to pills and injections.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Aquestive Therapeutics
Aquestive's balance sheet is its production lines for creating drug-based films. The market isn't evaluating these, but rather the potential of this unique drug delivery technology, which could replace injections and pills. The chart shows the premium investors are paying for this convenience and innovation.
Market to book capitalization ratio in a market segment - Pharma other
Aquestive Therapeutics develops drugs using its unique thin-film delivery technology (like a tongue patch). Its value lies in this platform. This chart shows how its market valuation, based on the potential of this technology, relates to its tangible assets.
Market to book capitalization ratio for the market as a whole
Aquestive Therapeutics develops drugs using its proprietary thin-film drug delivery technology. This enables it to improve existing drugs. Its value lies in this unique technology and partnerships. The chart shows how investors value this platform's potential for new product development, not its tangible assets.
Debts of the company, segment and market as a whole
AQST - Company debts Aquestive Therapeutics
Aquestive Therapeutics, a film-based drug delivery company, uses debt financing to bring its products to market. This chart shows how the company raises capital to commercialize its drugs and conduct clinical trials for new candidates based on its unique technology platform.
Market segment debts - Pharma other
Aquestive Therapeutics develops drugs using its unique orally dissolving film delivery technology. This innovation has the potential to improve existing treatments. The company's debt policy reflects its capital requirements for clinical trials. This chart shows how Aquestive funds its development efforts toward commercialization.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Aquestive Therapeutics
Aquestive Therapeutics develops unique drug delivery systems. As in traditional pharmaceuticals, the path from idea to market is long and expensive. This chart shows how much of this journey the company finances with debt, allowing investors to assess the level of financial risk associated with its innovative developments.
Market segment debt to market segment book capitalization - Pharma other
Aquestive Therapeutics, a pharmaceutical company specializing in the development of drugs delivered via oral films, compares its debt load to the overall market capitalization of the pharmaceutical sector. It shows how the company is financing its unique technology platform, aiming to offer an alternative to traditional pills and injections.
Debt to book value of all companies in the market
Aquestive Therapeutics develops drugs using its proprietary film-based drug delivery technology. Like many pharmaceutical companies, it requires funding before commercializing its products. This market debt chart shows its overall capital availability, which is important for assessing Aquestive's ability to raise funds for its innovative developments.
P/E of the company, segment and market as a whole
P/E - Aquestive Therapeutics
This chart for Aquestive Therapeutics illustrates the valuation of a pharmaceutical company with a unique thin-film drug delivery technology. Profitability depends on the success of its commercial products and partnerships. The metric reflects how investors view the potential of its platform to improve existing drugs and create new ones.
P/E of the market segment - Pharma other
Aquestive Therapeutics is a pharmaceutical company specializing in the development and commercialization of drugs delivered via oral films. This technology offers an alternative to tablets and injections. This chart shows the average valuation in the pharmaceutical industry, where investors evaluate the potential of innovative drug delivery systems.
P/E of the market as a whole
Aquestive Therapeutics develops drugs using its unique orally dissolving film delivery technology. This chart shows the overall risk appetite in the biotech sector. Comparison helps us understand whether Aquestive is valued based on the potential of its delivery platform or whether its value is driven by the overall speculative sentiment in the pharmaceutical industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Aquestive Therapeutics
This chart for Aquestive Therapeutics, a pharmaceutical company with a unique film-based drug delivery technology, reflects market expectations for future approvals and sales of its products. It demonstrates analysts' confidence in the commercial potential of this innovative platform and its ability to generate stable profits in the future.
%20P%2FE%20Aquestive%20Therapeutics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Aquestive-Therapeutics&v=1772635781954 "Chart of the company's future (projected) P/E Aquestive Therapeutics")
Future (projected) P/E of the market segment - Pharma other
Aquestive Therapeutics develops drugs using its proprietary film-based drug delivery technology, PharmFilm. This chart shows average expectations from the pharmaceutical sector. AQST's position may indicate the extent to which investors believe in the commercial potential of its technology and its ability to bring new, more patient-friendly drugs to market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772635781956 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Aquestive Therapeutics develops innovative drug delivery systems. Like many biotech companies, its value is determined not by the overall market, but by research successes and regulatory approvals. Nevertheless, investor optimism, evident in this chart, makes it easier to raise funding.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772635781979 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Aquestive Therapeutics
Aquestive Therapeutics develops and commercializes medications in the form of thin films that dissolve in the mouth (PharmFilm® technology). This graph illustrates innovations in drug delivery. The company's revenue growth will reflect the successful launch of new products and recognition by physicians and patients of the benefits of this delivery method.
Profit of companies in the market segment - Pharma other
Aquestive Therapeutics develops innovative drug delivery methods, such as dissolvable films. This allows for the improvement of existing drugs. The pharmaceutical sector's profitability depends on major blockbusters, but AQST prioritizes improvements. This chart illustrates the general context in which the company offers its technologies as a way to extend patents and improve therapeutics.
Overall market profit
Aquestive Therapeutics, which develops innovative drug delivery systems, such as film-based ones, is in a field where success is determined by technology and partnerships with pharmaceutical giants. While the economic cycles visible in this graph don't directly impact demand for their developments, the overall market situation influences partners' willingness to invest in new projects.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Aquestive Therapeutics
Aquestive Therapeutics develops oral film-based medications, an alternative to tablets and injections. This chart shows analysts' forecasts for future revenue, which depend on the approval and commercial success of its unique drug delivery technology. This is a bet on convenience and innovation in pharmacology.
%20profit%20of%20the%20company%20Aquestive%20Therapeutics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Aquestive-Therapeutics&v=1772635782043 "Graph of future (projected) profit of the company Aquestive Therapeutics")
Future (predicted) profit of companies in the market segment - Pharma other
Aquestive Therapeutics develops innovative drug delivery systems, such as orally dissolving films. The company improves existing medications, making them more convenient for patients. This chart illustrates the revenue forecast for the pharmaceutical industry, reflecting expected demand for new, more advanced dosage forms and therapeutic solutions.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772635782053 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Aquestive Therapeutics develops innovative drug delivery systems, such as film-based ones. Like many pharmaceutical companies, its key drivers are successful clinical trials and patents, not the economic situation. However, the overall negative market outlook may complicate raising capital or finding partners to commercialize its products.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772635782083 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Aquestive Therapeutics
Aquestive Therapeutics specializes in developing drugs delivered via oral film, an alternative to tablets and injections. Its revenue comes from sales of its own products and payments from partners. The chart shows how the market values each dollar of sales, factoring in the potential of its unique drug delivery technology.
P/S market segment - Pharma other
Aquestive Therapeutics develops medications in the form of thin films that dissolve in the mouth, offering an alternative to tablets and injections. The chart shows the average revenue estimate in the pharmaceutical industry, helping to understand how highly investors value the potential of this unique drug delivery technology compared to traditional pharmaceutical companies.
P/S of the market as a whole
Aquestive Therapeutics develops innovative drug delivery systems, such as orodispersible films. This technology has the potential to improve existing medications. The chart helps understand how the market values the company's revenue, whose success depends on partnerships with major pharmaceutical companies and the ability to commercialize its unique technology.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Aquestive Therapeutics
Aquestive Therapeutics is a pharmaceutical company with a unique thin-film drug delivery technology (PharmFilm®). The chart shows how the market values its innovative platform, shaping the company's value based on expected future revenues from its own drugs and partnerships with other pharmaceutical giants.
%20P%2FS%20Aquestive%20Therapeutics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Aquestive-Therapeutics&v=1772635782151 "The graph of the company's future (projected) P/S Aquestive Therapeutics")
Future (projected) P/S of the market segment - Pharma other
Aquestive Therapeutics develops drugs using its proprietary film-based drug delivery technology. This figure shows the average estimated future revenue for pharmaceutical companies. This allows investors to judge how highly the market values the commercial potential of this unique technology and the drugs in Aquestive's portfolio compared to competitors.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772635782183 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Aquestive Therapeutics develops innovative drug delivery systems. Its business depends on partnerships with major pharmaceutical companies and the approval of new products. This indicator of overall revenue expectations is not as important for the company. Aquestive's success depends on the uniqueness of its PharmFilm technology, which can improve existing drugs and create new ones.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772635782228 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Aquestive Therapeutics
Aquestive Therapeutics specializes in the innovative PharmFilm® thin-film drug delivery system. The company's revenue, as shown in this graph, is generated through sales of its own products developed using this technology and partner royalties. Sales growth confirms the commercial potential and recognition of this unique drug delivery method.
Sales of companies in the market segment - Pharma other
Aquestive Therapeutics develops innovative drug delivery systems, primarily in the form of orally dissolvable films. This technology improves drug absorption and patient convenience. This graph shows total revenue for the segment, reflecting the overall demand for new and more convenient pharmaceutical formulations and technologies.
Overall market sales
Aquestive Therapeutics develops unique drug delivery systems, such as oral films. This graph reflects the state of the economy, but for AQST, innovation and partnerships in the pharmaceutical industry are more important. The company's success depends on its ability to improve existing drugs, making them more convenient and effective, rather than on general economic trends.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Aquestive Therapeutics
Aquestive Therapeutics develops drugs using its proprietary film-based drug delivery technology (PharmFilm®). This enables improvements to existing treatments. The chart shows the commercial success projections for its unique products, including a treatment for epileptic seizures.
%20sales%20of%20the%20company%20Aquestive%20Therapeutics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Aquestive-Therapeutics&v=1772635782352 "Schedule of future (projected) sales of the company Aquestive Therapeutics")
Future (projected) sales of companies in the market segment - Pharma other
Aquestive Therapeutics is developing innovative drug delivery methods, such as thin films that dissolve in the mouth. This technology has the potential to improve treatment convenience and effectiveness. The graph shows forecasts for the entire pharmaceutical industry. Aquestive's success depends on partnerships with major pharmaceutical companies and the approval of its products.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772635782397 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Aquestive Therapeutics develops innovative drug delivery systems, such as film-based formulations. The company's commercial success depends on the healthcare system's ability to pay for new technologies. This chart, reflecting overall economic confidence, shows how likely it is that insurers and patients will be willing to pay for more convenient and effective drug delivery systems.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772635782430 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Aquestive Therapeutics
Aquestive Therapeutics develops unique drug delivery systems, such as oral films. Their profitability depends on successful partnerships with major pharmaceutical companies and the commercialization of their own products. This chart shows how the company manages R&D costs in an effort to monetize its innovative technology.
Market segment marginality - Pharma other
Aquestive Therapeutics develops drugs using its proprietary film-based drug delivery technology (PharmFilm®). This chart shows the average profitability in the pharmaceutical industry. This innovative delivery method, which improves drug convenience and safety, gives the company the potential to achieve above-market profitability.
Market marginality as a whole
Aquestive Therapeutics develops pharmaceuticals using its film-based drug delivery technology. This enables improvements to existing medications. The profitability of this model depends on partnerships with major pharmaceutical companies and successful product launches. This chart helps understand how innovations in drug delivery impact profitability.
Employees in the company, segment and market as a whole
Number of employees in the company Aquestive Therapeutics
Aquestive Therapeutics specializes in innovative film-based drug delivery technology. Its team is focused on refining this platform and conducting clinical trials. The growth in this graph is a positive sign, indicating that more and more partnered drugs or in-house developments are moving into active R&D.
Share of the company's employees Aquestive Therapeutics within the market segment - Pharma other
Aquestive Therapeutics develops innovative drug delivery methods, such as lozenges. This allows it to improve existing drugs. The company combines science and manufacturing. This graph shows its labor market share in the pharmaceutical industry, reflecting the balance between R&D specialists and production personnel.
Number of employees in the market segment - Pharma other
Aquestive Therapeutics, Inc. is a pharmaceutical company specializing in the development of drugs delivered through film technology. The dynamics in this graph reflect progress in research and commercialization. The increase in staff may be due to a drug entering late-stage trials or the creation of a sales team for the launch of a new product.
Number of employees in the market as a whole
Aquestive Therapeutics develops innovative drug delivery systems. Its business depends on the success of its developments and partnerships with major pharmaceutical companies, rather than on the overall economic situation, as reflected in this chart. The company solves specific medical problems, the value of which is independent of the labor market.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Aquestive Therapeutics (AQST)
Aquestive Therapeutics develops unique drug delivery systems (films). Its valuation is based on its patented technology. This chart illustrates how investors value innovation. Its high market capitalization is due to its small team of scientists and engineers, resulting in a very high ratio per employee.
%20of%20the%20company%20Aquestive%20Therapeutics%20(AQST)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Aquestive-Therapeutics-AQST&v=1772635782580 "Chart of market capitalization per employee (in thousands of dollars) of the company Aquestive Therapeutics (AQST)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Aquestive Therapeutics develops innovative drug delivery systems, such as film-based ones. The company is focused on R&D, and its market capitalization reflects the potential of its development pipeline rather than the size of its staff. This chart shows how the market values the company's intellectual capital and patents per research employee.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772635782593 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Aquestive Therapeutics develops drugs using a proprietary film-delivery technology. Innovative delivery is their key. The chart shows the valuation of the pharmaceutical technology. The high market capitalization per employee reflects the value of their unique platform, which has the potential to improve existing drugs.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772635782619 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Aquestive Therapeutics (AQST)
Aquestive Therapeutics uses a unique drug delivery technology—film strips. They either improve existing drugs or create new ones. This chart shows how effective this R&D and licensing business model is. It measures how much revenue (or R&D investment) accrues per employee working on this innovative platform.
%20Chart%20Aquestive%20Therapeutics%20(AQST)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Aquestive-Therapeutics-AQST&v=1772635782644 "Company Profit Per Employee (in thousands of dollars) Chart Aquestive Therapeutics (AQST)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Aquestive (AQST) is an R&D biotech company (with the approved drug Libervant). This chart shows the benchmark for "Pharma" (R&D). The average profit per employee in this sector (biotech) is high (if there's a hit). The benchmark reflects a "one-hit business": the sector spends millions on R&D, and a single successful orphan drug recoups all costs.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772635782674 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Aquestive Therapeutics develops drugs using its film-delivery technology (PharmFilm), allowing for injection-free administration. They have approved products. This chart demonstrates the effectiveness of their business model, which combines drug delivery R&D with the commercialization of approved products.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772635782693 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Aquestive Therapeutics (AQST)
Aquestive Therapeutics develops unique drug delivery systems. This chart shows how the company monetizes its technology platform. Increased revenue per employee is often driven by licensing agreements with major pharmaceutical companies, demonstrating the high value of its developments.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Aquestive-Therapeutics-AQST&v=1772635782735 "Sales chart per company employee Aquestive Therapeutics (AQST)")
Sales per employee in the market segment - Pharma other
Aquestive (AQST) is a pharmaceutical company specializing in a unique drug delivery system (pharmafilm) that dissolves in the mouth. This allows them to improve existing drugs. This graph shows their performance. Their revenue per employee depends on the success of licensing deals and sales of their own products (like Libervant) based on this technology.
Sales per employee for the market as a whole
Aquestive Therapeutics uses its own drug delivery technology (PharmFilm). This graph illustrates their business model. They can either develop their own products (which requires R&D) or license the technology to partners (which generates royalties). This metric reflects how successfully their R&D and sales teams are monetizing this unique platform.
Short shares by company, segment and market as a whole
Shares shorted by company Aquestive Therapeutics (AQST)
Aquestive (AQST) uses its proprietary PharmFilm technology—a thin film that dissolves in the mouth—to deliver drugs. It's an alternative to pills or injections, such as their seizure medication. This chart shows bearish bets. Are the bears doubting the FDA will approve their key drugs, or that doctors will prescribe them?
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Aquestive-Therapeutics-AQST&v=1772635782769 "Short Shares Chart for the Company Aquestive Therapeutics (AQST)")
Shares shorted by market segment - Pharma other
Aquestive Therapeutics (AQST) is a pharmaceutical company specializing in alternative drug delivery methods, primarily through dissolvable films (such as Listerine strips). This chart shows the odds against the specialty pharmaceutical sector. The rising odds against the industry reflect investor skepticism about AQST's ability to secure FDA approval for its key drugs.
Shares shorted by the overall market
Aquestive Therapeutics (AQST) is a pharmaceutical company specializing in the development of oral medications. These are an alternative to tablets and injections. This chart reflects overall market pessimism. When investors are fearful (the indicator rises), they avoid "risky" pharmaceutical companies that depend on FDA approval and the commercial success of new drug delivery systems.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Aquestive Therapeutics (AQST)
Aquestive Therapeutics uses a unique drug delivery technology—orally dissolving filmstrips. This is a bet on their epilepsy drug. This chart measures how investors view their chances against traditional pills, showing peaks of hype (overbought) or despair (oversold).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Aquestive-Therapeutics-AQST&v=1772635782825 "RSI 14 indicator chart for the company's stock Aquestive Therapeutics (AQST)")
RSI 14 Market Segment - Pharma other
Aquestive Therapeutics is a pharmaceutical company specializing in the development of oral film-based medications (PharmFilm). This technology enables drug delivery through the oral mucosa. This chart measures the overall momentum in the specialty pharmaceutical sector. It helps differentiate Aquestive's performance from the broader industry trend.
RSI 14 for the overall market
Aquestive Therapeutics (AQST) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AQST (Aquestive Therapeutics)
Aquestive Therapeutics is developing drugs using its PharmFilm film technology (sublingual dissolvable films) as an alternative to tablets and injections. This chart shows the average analyst forecast. Their targets are based on the success of approved drugs (for example, for seizures) and progress in developing new film-based drugs.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AQST-Aquestive-Therapeutics&v=1772635782894 "A chart showing analyst consensus forecasts for the expected stock price. AQST (Aquestive Therapeutics)")
The difference between the consensus estimate and the actual stock price AQST (Aquestive Therapeutics)
Aquestive Therapeutics is a pharmaceutical company specializing in alternative drug delivery methods. Their PharmFilm technology is a fast-dissolving film (like a Listerine strip) that delivers medication through the cheek. This chart shows how analysts rate their drugs (especially for epilepsy) that use this technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AQST-Aquestive-Therapeutics&v=1772635782935 "A chart showing the difference between the consensus forecast and the actual stock price. AQST (Aquestive Therapeutics)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Aquestive Therapeutics is a pharmaceutical company that uses its film technology (PharmFilm) to deliver drugs through the oral mucosa, replacing injections or tablets (for example, for seizures). This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe there will be demand for more convenient drug delivery methods.
Analysts' consensus forecast for the overall market share price
Aquestive Therapeutics is a pharmaceutical company specializing in the development of orally dissolving film-based medications (PharmFilm). These are an alternative to tablets and injections. This chart shows the overall risk appetite. For Aquestive, whose value depends on regulatory approval of their unique delivery system, overall market optimism is important for funding research and commercialization.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Aquestive Therapeutics
Aquestive Therapeutics (AQST) is a pharmaceutical company specializing in alternative drug delivery methods. Their signature product is PharmFilm, a thin, dissolvable film (similar to Listerine) that delivers medications through the oral mucosa. This chart is an assessment of their platform. It reflects their ability to convert existing drugs into this convenient form and gain FDA approval.
AKIMA Market Segment Index - Pharma other
Aquestive (AQST) is a biotech innovator in drug delivery; the company pioneered PharmFilm technology, a thin film (like Listerine) that delivers drugs (including epinephrine) through the oral mucosa. This summary metric evaluates R&D. The graph shows the segment average. This benchmark: how does this unique (PharmFilm) R&D platform (AQST) differentiate it from the average pharma company?
The AKIM Index for the overall market
Aquestive is a pharmaceutical company using oral film technology (PharmFilm) to deliver medications for epilepsy and allergies. This chart, reflecting the market average, provides a macro backdrop. It helps assess how this commercialization and R&D story compares to the overall economic trends affecting the sector.
